Related Experiment Video
Updated: Oct 12, 2025

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
Published on: September 17, 2019
Medicare Coverage of Aducanumab - Implications for State Budgets
Rachel E Sachs1, Nicholas Bagley1
1From Washington University School of Law, St. Louis (R.E.S.); and University of Michigan Law School, Ann Arbor (N.B.).
No abstract available in PubMed .
More Related Videos
09:54Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
Published on: May 22, 2020
09:31Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
Related Concept Videos
Standards of Care I
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Drug Products: Biologics, Biosimilars and Interchangeables
Alzheimer's Disease: Treatment
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...